PFE’s Embeda expected to be back on the US market in 2Q14, following FDA approval today of manufacturing change: http://finance.yahoo.com/news/pfizer-receives-fda-approval-prior-221400030.html PFE acquired Embeda as part of the King Pharma deal in 2010 (#msg-55459946).